Calamos Nasdaq-100 Structured Alt Protection ETF - December (CPNQ) seeks to provide exposure to the Nasdaq-100 Index while offering downside protection through structured product methodology. The Nasdaq-100 tracks the 100 largest non-financial companies listed on the Nasdaq exchange, representing major technology and growth companies.

How It Works

CPNQ employs a structured alternative protection strategy that combines Nasdaq-100 exposure with built-in downside buffers, typically protecting against the first 10-15% of losses over a defined outcome period ending in December. The fund uses options strategies and structured notes to create this protection profile while maintaining upside participation up to a predetermined cap. Holdings consist primarily of derivatives and cash equivalents rather than direct stock ownership.

Key Features

  • Provides built-in downside protection against initial market losses while maintaining upside exposure to Nasdaq-100 performance
  • December outcome period aligns protection and participation features with calendar year-end for tax planning purposes
  • Recently launched fund offering alternative approach to traditional Nasdaq-100 investing with structured product methodology

Risks

  • This ETF can lose value beyond the protection buffer if Nasdaq-100 declines exceed the predetermined threshold, potentially resulting in amplified losses
  • Upside participation is capped at a specific level, meaning investors miss gains above that threshold during strong market rallies
  • Complex derivatives structure creates counterparty risk and potential tracking errors versus direct Nasdaq-100 exposure during volatile market conditions

Who Should Own This

Best suited for moderate-risk investors with 1-3 year time horizons seeking Nasdaq-100 exposure with downside protection. Appropriate as a satellite holding (5-15% allocation) for those wanting technology growth potential while limiting drawdown risk. Requires understanding of structured products and acceptance of capped upside returns.